Good News From Canada

After more than a decade of extreme government and central bank interventions in financial markets and institutions all over the world, policies and actions are increasingly coming under a much needed scrutiny. This is a key step toward reigning in what has been a runaway finance sector and remind policy makers that their fiduciary duty as elected and appointed officials, is not owed to profit-maximizing banks, but to the taxpayers and citizens of the country.
The pendulum seems to be finally swinging back toward fiscal restraint, aversion to debt, and democratic accountability. Recent attention on the negotiations in Greece are one example. This interesting case in Canada, is another. See: The Canadian court case the mainstream media won’t cover.

In this recent case, Canadians sued the Bank of Canada and won. Here is a direct video link.

For more background on Canadian constitutional lawyer, Rocco Galati, who argued the case, see The Globe’s recent interview with him here: The lawyer who challenged the Harper Government and won.

Please share this article

Is The “Other” Most Crowded Trade Of 2015 Starting To Crack?

zerohedge.com / by Tyler Durden on 02/03/2015 11:57
With the recent collapse of Treasury yields, the massive short position in bonds has been dramatically unwound (though there is still plenty left). However, there is the other “most crowded” trade in the world – Long The USDollar – that remains… but is starting to show some cracks in the armor. Despite the highest levels of Short EUR, Long USD since the very peak of the EU Crisis in 2012 and still massively long net dollar positions across sell-side OTC indications and CFTC exchange-traded positions,the last 2 days have seen the biggest drop in the USD Index since September 2013… is the world’s most crowded trade about to unwind?
No one has started to fold yet…
READ MORE

Please share this article

Caterpillar (NYSE: CAT) stock is too good to pass up

There are two technical directives battling for the fortunes of Caterpillar (NYSE: CAT) right now. The first says to never try to catch a falling knife. The other, which traces back to 19th-century banker Baron Nathan Rothschild, says to buy when there's blood in the streets.
But when we toss a few more conditions into the mix, namely major support, terrible sentiment and a beefy dividend yield, the battle goes to the baron.
This blue-chip stock has likely seen the worst of its bear market and will pay us to hold it while we wait for better times that should be coming.
Shares of the heavy equipment maker certainly fell hard over the past six months from a perch above $111 to their current price at $80. That nearly 30% decline qualifies as a full-fledged bear market.  (more)

Please share this article

Tenet Healthcare Corp (NYSE: THC)

Tenet Healthcare Corporation, an investor-owned health care services company, primarily operates acute care hospitals and related health care facilities in the United States. Its general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies. As of December 31, 2013, it operated 77 hospitals with 20,293 beds; 183 outpatient centers; 6 health plans; 6 accountable care networks; and Conifer Health Solutions, LLC, which provides business process solutions to approximately 700 hospital and other clients. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Take a look at the 1-year chart of Tenet (NYSE: THC) with the added notations:

THC had a great summer, but declined from there just as badly as it had rallied. Over the last year, the stock has created a key price level at $44 (blue), which has been support the last 3 times that level has been tested. Now that the stock appears to be have broken that support, lower prices should follow.

The Tale of the Tape: THC broke a key level of support at $44. A trader could enter a short position on any rallies up to or near $44 with a stop placed above the level. If the stock were to break back above the $44 level, a long position could be entered instead.
Please share this article

Chart of the Day - Neovasc (NVCN)

Neovasc Inc. is a specialty medical device company. It develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Tiara (TM) mitral valve prosthesis in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer (TM) for the treatment of refractory angina and a line of advanced biological tissue products that are used as key components in third-party medical products, including transcatheter heart valves.

 Please share this article

Is Gold on the Verge of a Major Trend Change?

All major U.S. indices closed in negative territory last week, led by the tech-heavy Nasdaq 100, which ended down 2.1% in January.

As I said in last week's report, even though the recent sideways trading activity tends to lull people to sleep, this is a time when investors should be paying particularly close attention to day-to-day market movement. These periods of investor indecision typically become the springboard for the next investable intermediate-term trend. (more)

Please share this article